By Steve Holland, Saad Sayeed and Asif Shahzad WASHINGTON/ISLAMABAD, April 26 (Reuters) - President Donald Trump said on ...
By Saad Sayeed, Asif Shahzad and Steve HollandISLAMABAD/WASHINGTON, April 26 (Reuters) - U.S. President Donald Trump said on ...
Program provides access to leronlimab for patients with limited treatment options while supporting ongoing clinical developmentVANCOUVER, ...
NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and ...
NervGen Pharma Corp. ("NervGen" or the "Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class ...